✨ Classification of Medicines
2710
NEW ZEALAND GAZETTE, No. 112
not more than 600 milligrams and with a recommended
daily dose of not more than 120 milligrams
Diclofenac; in solid dose form containing 12.5 milligrams or
less per dose form in packs of not more than 20 tablets
or capsules
Duboisia leichhardtii; for oral use in liquid form in
medicines containing 0.03% or less and 0.3 milligrams
or less per dose and not more than 1.2 milligrams per
recommended daily dose of total solanaceous alkaloids
or in solid dose form in medicines containing 0.3
milligrams or less per dose form and not more than 1.2
milligrams per recommended daily dose of total
solanaceous alkaloids
Duboisia myoporides; for oral use in liquid form in
medicines containing 0.03% or less and 0.3 milligrams
or less per dose and not more than 1.2 milligrams per
recommended daily dose of total solanaceous alkaloids
or in solid dose form in medicines containing 0.3
milligrams or less per dose form and not more
than 1.2 milligrams per recommended daily dose of total
solanaceous alkaloids
Fluorides; for internal use in medicines containing
2.2 milligrams or less per dose form of sodium fluoride;
for external use in medicines other than pastes, gels or
powders for cleaning the teeth containing 2.5% or less;
except in dental hygiene products other than pastes,
gels or powders for cleaning the teeth containing 220
milligrams or less per litre or per kilogram and in packs
containing not more than 120 milligrams of total fluoride
Flurbiprofen; in throat lozenges containing 10 milligrams
or less per lozenge
*Fluticasone; in aqueous nasal sprays delivering up to
50 micrograms per actuation when the maximum
recommended daily dose is not greater than 200
micrograms and the medicine has received the consent
of the Minister or the Director-General to its distribution
as a pharmacy-only medicine
Folic acid; for oral use in medicines containing more than
500 micrograms per recommended daily dose
Folinic acid; for oral use in medicines containing more than
500 micrograms per recommended daily dose
Glyceryl trinitrate; for external use; except in medicines
containing 100 micrograms or less per litre or per
kilogram
Hydroquinone; for external use in medicines containing
2% or less except in hair preparations containing 1% or
less
Hyoscine; for transdermal use in medicines containing
2 milligrams or less of total solanaceous alkaloids per
dose unit; for oral use in liquid form in medicines
containing 0.03% and 0.3 milligrams or less per dose
and not more than 1.2 milligrams per recommended
daily dose or in solid dose form in medicines containing
0.3 milligrams or less per dose unit and not more than
1.2 milligrams per recommended daily dose of total
solanaceous alkaloids
Hyoscyamine; for external use in medicines containing
0.03% or less of total solanaceous alkaloids; for oral
use in liquid form in medicines containing 0.03% and
0.3 milligrams or less per dose and not more than
1.2 milligrams per recommended daily dose or in solid
dose form in medicines containing 0.3 milligrams or less
per dose unit and not more than 1.2 milligrams per
recommended daily dose of total solanaceous alkaloids
Hyoscyamus niger; for oral use in liquid form in medicines
containing 0.03% and 0.3 milligrams or less per dose
and not more than 1.2 milligrams per recommended
daily dose of total solanaceous alkaloids or in solid dose
form in medicines containing 0.3 milligrams or less
28 JULY 2005
per dose unit and not more than 1.2 milligrams per
recommended daily dose except in packs containing
30 micrograms or less of total solanaceous alkaloids
Ibuprofen; for oral use in liquid form in packs containing
not more than 4 grams in medicines which have received
the consent of the Minister or the Director-General to
their sale as pharmacy-only medicines and which are
sold in the manufacturer’s original pack; for oral use in
solid dose form containing not more than 200 milligrams
per dose form in medicines which have received the
consent of the Minister or the Director-General to their
sale as pharmacy-only medicines and which are sold in
the manufacturer’s original pack; except in packs
containing 200 milligrams or less per oral solid dose
form and not more than 25 dose units per pack when in
medicines which have received the consent of the
Minister or the Director-General to their sale as general
sale medicines and which are sold in the manufacturer’s
original pack
Lignocaine; for external use in medicines containing 10% or
less and more than 2%; for urethral use
Minoxidil; for external use in medicines containing 5% or
less
Mometasone; in aqueous nasal sprays delivering up
to 50 micrograms per actuation when the maximum
recommended daily dose is not greater than 200
micrograms and the medicine has received the consent
of the Minister or the Director-General to its distribution
as a pharmacy-only medicine
Nicotine; for inhalation except when sold from a smoking
cessation clinic run under the auspices of a registered
medical practitioner, nurse, pharmacist or psychologist
*Nizatidine; in medicines which have received the consent
of the Minister or the Director-General to their sale as
pharmacy-only medicines and which are sold in the
manufacturer’s original pack containing not more than
14 days’ supply
Nystatin; for dermal use
Phenylephrine; for nasal use in medicines containing more
than 1%; for ophthalmic use in medicines containing 5%
or less and more than 1%; for oral use in medicines
containing more than 50 milligrams per recommended
daily dose and in packs containing more than 250
milligrams of phenylephrine per pack
Podophyllotoxin; for external use for the treatment of warts
other than anogenital warts in medicines containing
0.5% or less
Podophyllum emodi; for external use for the treatment
of warts other than anogenital warts in medicines
containing 10% or less of podophyllin
Podophyllum peltatum; for external use for the treatment
of warts other than anogenital warts in medicines
containing 10% or less of podophyllin
Potassium chlorate; except in medicines containing 10% or
less
Prilocaine; for dermal use in medicines containing 10% or
less
Pyrithione zinc; for external use in medicines containing
more than 2%
Sabadilla; in packs containing 18 milligrams or less of
total alkaloids except in packs containing 1.8 milligrams
or less and a recommended daily dose of not more than
0.6 milligrams of total alkaloids
Silver; except in oral solutions containing 0.3% or less or
other medicines containing 1% or less
Silver sulfadiazine; for external use in packs containing
50 grams or less
Sodium picosulfate; for laxative use
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2005, No 112
Gazette.govt.nz —
NZ Gazette 2005, No 112
✨ LLM interpretation of page content
🏥
Classification of Medicines
(continued from previous page)
🏥 Health & Social WelfareMedicines Act, Classification, Prescription, Restricted, Pharmacy-only